messenger RNA; neutralizing antibody; vaccine; adult; antibody response; cancer patient; cancer therapy; chemotherapy; clinical outcome; conference abstract; controlled study; coronavirus disease 2019; drug megadose; drug therapy; female; hematologic malignancy; human; immunogenicity; immunotherapy; major clinical study; male; mandatory reporting; medical record; multicenter study; nonhuman; outcome assessment; seroconversion; Severe acute respiratory syndrome coronavirus 2; Singapore; solid tumor; surrogate virus neutralization test; vaccination